Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0164 USD | -21.90% | +0.61% | -36.68% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 75 | 31/01/14 | |
Evan Wasoff
DFI | Director of Finance/CFO | 77 | - |
Jeremy Reeh
CTO | Chief Tech/Sci/R&D Officer | - | 25/10/18 |
Robert Goldfarb
COO | Chief Operating Officer | 69 | - |
Frank Manganella
PRN | Corporate Officer/Principal | 58 | 29/10/18 |
Joseph Aceto
PRN | Corporate Officer/Principal | 66 | 29/10/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lindy Snider
BRD | Director/Board Member | 64 | 25/01/18 |
Chief Executive Officer | 75 | 31/01/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,472,196 | 30,966,703 ( 45.90 %) | 0 | 45.90 % |
Company contact information
Nexien BioPharma, Inc.
4340 East Kentucky Avenue Suite 206
80246, Glendale
+303 495 7583
http://www.nexienbiopharma.comSector
1st Jan change | Capi. | |
---|---|---|
-36.68% | 1.11M | |
+38.51% | 727B | |
+32.04% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+14.15% | 243B | |
+8.06% | 205B | |
-5.32% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- NXEN Stock
- Company Nexien BioPharma, Inc.